Funder: Breakthrough T1D
Due Dates: January 10, 2025 (Letter of Intent) | February 21, 2025 (Full proposal)
Funding Amounts: Up to $300,000 per year for 2 years (total up to $600,000); larger awards possible with prior approval.
Summary: Supports research to advance technologies enhancing survival and engraftment of insulin-producing cells at alternative transplantation sites for type 1 diabetes cell therapy.